Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

dc.creatorKumar Singh, Awadhesh
dc.creatorGupta, Ritesh
dc.creatorGhosh, Amerta
dc.creatorMisra, Anoop
dc.date.accessioned2020-07-29T19:43:29Z
dc.date.accessioned2022-09-23T18:46:45Z
dc.date.available2020-07-29T19:43:29Z
dc.date.available2022-09-23T18:46:45Z
dc.date.created2020-07-29T19:43:29Z
dc.identifier1871-4021
dc.identifierhttps://doi.org/10.1016/j.dsx.2020.04.004
dc.identifierhttp://hdl.handle.net/20.500.12010/11367
dc.identifierhttps://doi.org/10.1016/j.dsx.2020.04.004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3507236
dc.description.abstractBackground and aims: High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and COVID-19, pathophysiology of the disease in diabetes and management of patients with diabetes who develop COVID-19 infection. Methods: PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARSCoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020. Full texts of the retrieved articles were accessed. Results: There is evidence of increased incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have effect on the pathophysiology of diabetes. Blood glucose control is important not only for patients who are infected with COVID-19, but also for those without the disease. Innovations like telemedicine are useful to treat patients with diabetes in today’s times.
dc.publisherClinical Research and Reviews
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID-19
dc.subjectPathophysiology
dc.subjectDiabetes
dc.titleDiabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations


Este ítem pertenece a la siguiente institución